CryoStasis Information

CryoStasis is a biotech company specializing in bio-preservation of cells, tissues and organs. Located in Ottawa and based on 30 years of pioneering research in the Canadian Arctic, we have developed a method that overturns the long-held belief that biological material must be frozen for its function to be preserved. By using rationally designed cryoprotectants (Woolii™Cool media) along with temperature and pressure management systems (Woolii™Pod), our platform drops temperatures well below freezing, halting cellular metabolism WITHOUT TURNING WATER INTO ICE. Maintaining sub-zero, unfrozen conditions induces stasis (indefinite preservation) while avoiding the dramatic loss of cell function, therapeutic potency and manufacturing yield that occur as a result of freeze-thaw damage. CryoStasis works with BioPharma, CDMOs and research institutions to help ensure life-changing cell & gene therapies can be produced at-scale economically, and reach patients whenever / wherever they are needed.

Website	https://www.cryostasis.ca
Employees	6 (6 on RocketReach)
Founded	2022
Industry	Medical Equipment Manufacturing
Keywords	Biopreservation, Cryopreservation, Cell Preservation, Tissue Preservation, Organ Preservation, Biotechnology, Biomedical, Tissue Storage, Cold Storage, Freezing Technology, Preservation Solutions, Cryogenic Storage, Low Temperature Storage, Biological Samples, Sample Preservation, Medical Technology, Biobanking
Competitors	Oxford Women in Physics, CryoFuture, Alcor Life Extension Foundation, Tomorrow Biostasis GMBH, Cronics, Inc., American Cryonics Society, REVIVE AND RESTORE MINISTRIES, BioPreserve, SUSPENDED ANIMATION, INC., KrioRus +9 more (view full list)